✦ LIBER ✦

P-3 A phase II trial of the combination of temozolomide and irinotecan as second-line therapy for patients with non-small cell lung cancer

✍ Scribed by Winegarden, Jerome D.; Rudin, Charles M.; Mauer, Ann M.; Hoffman, Philip; Szeto, Livia; Eileen Dolan, M.; Vokes, Everett E.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of gemcitabine as second

✍ Gillenwater, HH; Tynan, M; Socinski, MA 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 129 KB

P-473 Phase II trial of temozolomide and

✍ Choong, N.; Mauer, A.; Hoffman, P.; Ma, P.; Cohen, E.; Rudin, C.; Kozloff, M.; S 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Phase II trial of the combination of car

✍ Yasunori Murata; Takashi Hirose; Toshimitsu Yamaoka; Takao Shirai; Kentaro Okuda 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 255 KB

Phase II study of weekly paclitaxel as s

✍ Ceresoli, Giovanni Luca; Gregorc, Vanesa; Cordio, Stefano; Bencardino, Katia Bru 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Phase II trial of weekly docetaxel and g

✍ Sujith Kalmadi; Giles McNeill; Mellar Davis; David Peereboom; David Adelstein; T 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 68 KB

Second-line therapy with gefitinib in co

✍ G. Robinet; F. Barlesi; P. Fournel; H. Berard; R. Corre; A. Vergnenegre; L. Falc 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 160 KB